Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

Phase 2

Terminated

Conditions: Stomach Neoplasms

Interventions: Drug: AZD2014

First Posted Date: 2017-02-23

Last Posted Date: 2019-05-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1

Registration Number: NCT03061708

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients

Phase 2

Conditions: Stage IIIA Non-small Cell Lung Cancer

Interventions: Drug: Pembrolizumab
Procedure: Curative resection
Procedure: Neoadjuvant concurrent chemoradiotherapy
Drug: Cisplatin
Drug: Paclitaxel

First Posted Date: 2017-02-15

Last Posted Date: 2017-02-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 37

Registration Number: NCT03053856

Locations: 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression

Phase 2

Completed

Conditions: Stomach Neoplasms

Interventions: Drug: Vismodegib 150 mg

First Posted Date: 2017-02-14

Last Posted Date: 2021-06-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 10

Registration Number: NCT03052478

Locations: 🇰🇷
Samsung Medical Center, Seoul City, Seoul, Korea, Republic of

A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI

Phase 2

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Cisplatin
Drug: Pemetrexed

First Posted Date: 2017-02-10

Last Posted Date: 2017-02-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 96

Registration Number: NCT03050437

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults

Not Applicable

Completed

Conditions: Healthy
Stroke

Interventions: Procedure: Gait, sit-to-stand movement, stair climbing and treadmill gait
Procedure: Sit-to-stand movement and treadmill gait
Device: gait enhancing mechatronic system (GEMS)
Device: treadmill

First Posted Date: 2017-02-09

Last Posted Date: 2019-04-29

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT03048968

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill Patients

Not Applicable

Conditions: ICU Patients

Interventions: Diagnostic Test: kidney function assessment by creatinine based eGFR
Diagnostic Test: kidney function assessment by 4 hour creatinine clearance

First Posted Date: 2017-02-07

Last Posted Date: 2017-02-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 172

Registration Number: NCT03045692

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

Active, not recruiting

Conditions: Ischemic Heart Disease

Interventions: Device: Comprehensive physiologic evaluation
Device: Intravascular imaging devices

First Posted Date: 2017-01-25

Last Posted Date: 2024-04-22

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1400

Registration Number: NCT03030495

Locations: 🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Korea, Republic of
🇰🇷
Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

and more 1 locations

Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations

Phase 2

Completed

Conditions: Small Cell Lung Cancer

Interventions: Drug: Olaparib

First Posted Date: 2017-01-04

Last Posted Date: 2021-02-18

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 15

Registration Number: NCT03009682

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)

Not Applicable

Completed

Conditions: Alopecia
Chemotherapy Effects

Interventions: Other: CG428

First Posted Date: 2016-12-08

Last Posted Date: 2018-09-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 19

Registration Number: NCT02986412

Locations: 🇰🇷
Danbee Kang, Seoul, Korea, Republic of

Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation

Not Applicable

Conditions: Stress, Psychological
Motion Sickness
Visual Fatigue

Interventions: Device: Existing Biofeedback
Device: Biofeedback accompanied with virtual reality

First Posted Date: 2016-12-08

Last Posted Date: 2016-12-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 80

Registration Number: NCT02986555

Locations: 🇰🇷
Samsung Medical Center, Seoul, Irwon-dong, Gangnam-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy